Liver International

Hepatitis B and hepatitis C in 2009
pp. 1-8(8)
Author: Marcellin, Patrick

How to use virological tools for optimal management of chronic hepatitis C
pp. 9-14(6)
Authors: Chevaliez, Stéphane; Pawlotsky, Jean-Michel

What are the comorbidities influencing the management of patients and the response to therapy in chronic hepatitis C?
pp. 15-18(4)
Author: Alberti, Alfredo

Assessment of hepatitis C: non-invasive fibrosis markers and/or liver biopsy
pp. 19-22(4)
Author: Bedossa, Pierre

Optimal therapy in genotype 1 patients
pp. 23-30(8)
Authors: Farnik, Harald; Mihm, Ulrike; Zeuzem, Stefan

Optimizing the treatment of chronic hepatitis due to hepatitis C virus genotypes 2 and 3: a review
pp. 31-38(8)
Authors: Tarantino, Giuseppe; Craxì, Antonio

Hepatitis C genotype 4 therapy: increasing options and improving outcomes
pp. 39-48(10)
Author: Kamal, Sanaa M.

Retreatment of chronic hepatitis C: who and how?
pp. 49-56(8)
Author: Heathcote, Jenny

Protease and polymerase inhibitors for the treatment of hepatitis C
pp. 57-67(11)
Authors: Asselah, Tarik; Benhamou, Yves; Marcellin, Patrick

What future for ribavirin?
pp. 68-73(6)
Author: Shiffman, Mitchell L.

The global burden of hepatitis C
pp. 74-81(8)
Author: Lavanchy, Daniel

Discovery of the hepatitis C virus
pp. 82-88(7)
Author: Houghton, Michael

The history of the “natural history” of hepatitis C (1968-2009)
pp. 89-99(11)
Author: Seeff, Leonard B.

Natural history of chronic hepatitis B virus infection and long-term outcome under treatment
pp. 100-107(8)
Author: Liaw, Yun-Fan

Management and prevention of drug resistance in chronic hepatitis B
pp. 108-115(8)
Authors: Zoulim, Fabien; Durantel, David; Deny, Paul

Treatment of HBeAg-positive patients with nucleos/tide analogues
pp. 116-124(9)
Authors: Coffin, Carla S.; Lee, Samuel S.

HBeAg-positive chronic hepatitis B: why do I treat my patients with pegylated interferon
pp. 125-129(5)
Author: Lau, George K. K.

HBeAg-negative chronic hepatitis B: why do I treat my patients with nucleos(t)ide analogues
pp. 130-132(3)
Authors: Lampertico, Pietro; Colombo, Massimo

Hepatitis B and pregnancy: an underestimated issue
pp. 133-139(7)
Author: Jonas, Maureen M.

Hepatitis D: the comeback?
pp. 140-142(3)
Author: Rizzetto, Mario

Screening and diagnosis of hepatocellular carcinoma
pp. 143-147(5)
Author: Colombo, Massimo

New drugs for the treatment of hepatocellular carcinoma
pp. 148-158(11)
Authors: Boucher, Eveline; Forner, Alejandro; Reig, Maria; Bruix, Jordi